Narrow search
Showing 1 - 10 of 112
Cover Image
Health state utilities associated with post-surgical Staphylococcus aureus infections
Matza, Louis S.; Kim, Katherine J.; Yu, Holly; Belden, … - In: The European journal of health economics : HEPAC ; … 20 (2019) 6, pp. 819-827
Persistent link: https://www.econbiz.de/10012061291
Cover Image
Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial
Garattini, Livio; Curto, Alessandro; Van de Vooren, … - In: The European journal of health economics : HEPAC ; … 16 (2015) 7, pp. 683-687
Persistent link: https://www.econbiz.de/10011482938
Cover Image
Recommendation of rotavirus vaccination and herd effect : a budget impact analysis based on German health insurance data
Karmann, Alexander; Jurack, Andrea; Lukas, Daniel - In: The European journal of health economics : HEPAC ; … 16 (2015) 7, pp. 719-731
Persistent link: https://www.econbiz.de/10011482970
Cover Image
Parallel imports and a mandatory substitution reform : a kick or a muff for price competition in pharmaceuticals?
Granlund, David; Koksal-Ayhan, Miyase Yesim - In: The European journal of health economics : HEPAC ; … 16 (2015) 9, pp. 969-983
Persistent link: https://www.econbiz.de/10011483923
Cover Image
Some economics on personalized and predictive medicine
Antoñanzas Villar, Fernando; Juárez-Castelló, C.A.; … - In: The European journal of health economics : HEPAC ; … 16 (2015) 9, pp. 985-994
Persistent link: https://www.econbiz.de/10011483931
Cover Image
Entry time effects and follow-on drug competition
Andrade, Luiz Flavio; Sermet, Catherine; Pichetti, Sylvain - In: The European journal of health economics : HEPAC ; … 17 (2016) 1, pp. 45-60
Persistent link: https://www.econbiz.de/10011486246
Cover Image
Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany
Herpers, Matthias; Dintsios, Charalabos-Markos - In: The European journal of health economics : HEPAC ; … 20 (2019) 1, pp. 45-57
Persistent link: https://www.econbiz.de/10011998030
Cover Image
Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany
Pöllinger, Bernadette; Schmidt, Wolfgang; Seiffert, Anna; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 195-203
Persistent link: https://www.econbiz.de/10012004819
Cover Image
Pricing of HPV vaccines in European tender-based settings
Qendri, Venetia; Bogaards, Johannes A.; Berkhof, Johannes - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 271-280
Persistent link: https://www.econbiz.de/10012004859
Cover Image
A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer
Nguyen Cuc Thi Thu; Petrelli, Fabio; Scuri, Stefania; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 5, pp. 763-777
Persistent link: https://www.econbiz.de/10012061274